These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 35242941)
1. Data on body mass, glucose tolerance and bone phenotype of mice with osteogenesis imperfecta on long-term low-fat and high-fat diets. Tauer JT; Boraschi-Diaz I; Komarova SV Data Brief; 2022 Apr; 41():107961. PubMed ID: 35242941 [TBL] [Abstract][Full Text] [Related]
2. Male but not female mice with severe osteogenesis imperfecta are partially protected from high-fat diet-induced obesity. Tauer JT; Boraschi-Diaz I; Al Rifai O; Rauch F; Ferron M; Komarova SV Mol Genet Metab; 2021 Jun; 133(2):211-221. PubMed ID: 33814269 [TBL] [Abstract][Full Text] [Related]
3. Effects of treatment with a bone-targeted prostaglandin E2 receptor 4 agonist C3 (Mes-1007) in a mouse model of severe osteogenesis imperfecta. Boraschi-Diaz I; Chen G; Polak-Nachumow J; Young RN; Rauch F Bone; 2021 Apr; 145():115867. PubMed ID: 33524637 [TBL] [Abstract][Full Text] [Related]
4. Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats. Shen CL; Zhu W; Gao W; Wang S; Chen L; Chyu MC Nutr Res; 2013 Aug; 33(8):668-76. PubMed ID: 23890357 [TBL] [Abstract][Full Text] [Related]
5. Are Changes in Composition in Response to Treatment of a Mouse Model of Osteogenesis Imperfecta Sex-dependent? Boskey AL; Marino J; Spevak L; Pleshko N; Doty S; Carter EM; Raggio CL Clin Orthop Relat Res; 2015 Aug; 473(8):2587-98. PubMed ID: 25903941 [TBL] [Abstract][Full Text] [Related]
6. A High Fat Diet Increases Bone Marrow Adipose Tissue (MAT) But Does Not Alter Trabecular or Cortical Bone Mass in C57BL/6J Mice. Doucette CR; Horowitz MC; Berry R; MacDougald OA; Anunciado-Koza R; Koza RA; Rosen CJ J Cell Physiol; 2015 Sep; 230(9):2032-7. PubMed ID: 25663195 [TBL] [Abstract][Full Text] [Related]
7. Bone Marrow Transplantation for Treatment of the Col1a2 Lee LR; Peacock L; Ginn SL; Cantrill LC; Cheng TL; Little DG; Munns CF; Schindeler A Calcif Tissue Int; 2019 Apr; 104(4):426-436. PubMed ID: 30535573 [TBL] [Abstract][Full Text] [Related]
8. Bone quality and strength are greater in growing male rats fed fructose compared with glucose. Bass EF; Baile CA; Lewis RD; Giraudo SQ Nutr Res; 2013 Dec; 33(12):1063-71. PubMed ID: 24267046 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E-dependent inverse regulation of vertebral bone and adipose tissue mass in C57Bl/6 mice: modulation by diet-induced obesity. Bartelt A; Beil FT; Schinke T; Roeser K; Ruether W; Heeren J; Niemeier A Bone; 2010 Oct; 47(4):736-45. PubMed ID: 20633710 [TBL] [Abstract][Full Text] [Related]
10. High bone mass in adult mice with diet-induced obesity results from a combination of initial increase in bone mass followed by attenuation in bone formation; implications for high bone mass and decreased bone quality in obesity. Lecka-Czernik B; Stechschulte LA; Czernik PJ; Dowling AR Mol Cell Endocrinol; 2015 Jul; 410():35-41. PubMed ID: 25576855 [TBL] [Abstract][Full Text] [Related]
11. Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta. Roschger A; Roschger P; Keplingter P; Klaushofer K; Abdullah S; Kneissel M; Rauch F Bone; 2014 Sep; 66():182-8. PubMed ID: 24953712 [TBL] [Abstract][Full Text] [Related]
12. Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta. Kocijan R; Muschitz C; Haschka J; Hans D; Nia A; Geroldinger A; Ardelt M; Wakolbinger R; Resch H Osteoporos Int; 2015 Oct; 26(10):2431-40. PubMed ID: 25956285 [TBL] [Abstract][Full Text] [Related]
13. Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta. Little DG; Peacock L; Mikulec K; Kneissel M; Kramer I; Cheng TL; Schindeler A; Munns C Bone; 2017 Aug; 101():96-103. PubMed ID: 28461254 [TBL] [Abstract][Full Text] [Related]
14. Distinct Effects of a High Fat Diet on Bone in Skeletally Mature and Developing Male C57BL/6J Mice. Ross DS; Yeh TH; King S; Mathers J; Rybchyn MS; Neist E; Cameron M; Tacey A; Girgis CM; Levinger I; Mason RS; Brennan-Speranza TC Nutrients; 2021 May; 13(5):. PubMed ID: 34068953 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Misof BM; Roschger P; Baldini T; Raggio CL; Zraick V; Root L; Boskey AL; Klaushofer K; Fratzl P; Camacho NP Bone; 2005 Jan; 36(1):150-8. PubMed ID: 15664013 [TBL] [Abstract][Full Text] [Related]
16. The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment. Liu Y; Ju M; Wang Z; Li J; Shao C; Fu T; Jing Y; Zhao Y; Lv Z; Li G Biomed Pharmacother; 2020 Aug; 128():110235. PubMed ID: 32454289 [TBL] [Abstract][Full Text] [Related]
18. Acute and long-term effects of zoledronate in adult patients with osteogenesis imperfecta. An observational Spanish study with five years of follow-up. Pavón de Paz I; Rosado Sierra JA; Pérez Blanco C; Modroño Móstoles N; Guijarro de Armas G; Navea Aguilera C Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):108-116. PubMed ID: 30077631 [TBL] [Abstract][Full Text] [Related]
19. Raloxifene reduces skeletal fractures in an animal model of osteogenesis imperfecta. Berman AG; Wallace JM; Bart ZR; Allen MR Matrix Biol; 2016; 52-54():19-28. PubMed ID: 26707242 [TBL] [Abstract][Full Text] [Related]
20. Analysis of bone architecture using fractal-based TX-Analyzer™ in adult patients with osteogenesis imperfecta. Schanda JE; Huber S; Behanova M; Haschka J; Kraus DA; Meier P; Bahrami A; Zandieh S; Muschitz C; Resch H; Mähr M; Rötzer K; Uyanik G; Zwerina J; Kocijan R Bone; 2021 Jun; 147():115915. PubMed ID: 33722771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]